← Vita Coco Company, Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Net income $9.4m
$32.7m +246.92%
$19.0m -41.90%
$7.8m -58.86%
$46.6m +496.74%
$56.0m +19.99%
$71.3m +27.47%
$109.5m +53.47%
Depreciation and amortization $2.1m $2.1m $2.1m $1.9m $660k $745k $1.1m $1.6m
Amortization of debt issuance costs — — — — $0 $0 $16k —
Depreciation Amortization Depletion — — — $1.9m $660k $745k $1.1m $1.6m
Deferred tax expense ($788k) $6.3m ($1.6m) ($3.1m) ($2.4m) $644k ($366k) —
Deferred Income Tax — — — ($3.1m) ($2.4m) $644k ($366k) ($366k)
Stock-based compensation $2.2m $1.5m $3.4m $7.4m $9.1m $8.9m $10.8m $13.9m
Impairment loss on assets held for sale — $90k $0 $619k $363k $0 $0 —
Impairment loss on Runa assets $0 $90k $0 $6.7m $0 $0 $185k —
Asset Impairment Charge — — — $10.0m $623k $1.6m $2.2m $771k
Equity method investment in joint venture — — — — $0 $0 ($104k) —
Change In Working Capital — — — ($29.4m) $50.3m ($34.2m) ($34.5m) $8.2m
Accounts receivable ($4.9m) $190k ($16.9m) $321k ($7.1m) ($14.2m) ($18.6m) ($31.4m)
Change In Receivables — — — $321k ($7.1m) ($14.2m) ($18.6m) ($31.4m)
Changes In Account Receivables — — — $321k ($7.1m) ($14.2m) ($18.6m) ($31.4m)
Inventory $11.1m $5.0m ($43.5m) ($9.3m) $33.7m ($33.0m) ($27.3m) $858k
Accounts payable, accrued expenses, and other liabilities ($3.6m) $12.7m $20.5m ($16.8m) $24.3m $15.7m $11.2m $23.9m
Prepaid expenses, net supplier advances, and other assets $3.3m ($16.8m) $2.6m ($3.6m) ($622k) ($2.7m) $130k —
Net cash provided by operating activities $21.8m
$33.3m +53.10%
($16.2m) -148.51%
($10.9m) +32.36%
$107.2m +1079.93%
$42.9m -59.97%
$47.2m +9.97%
$131.7m +179.16%
Loss on disposal of equipment ($2k) ($5k) $112k $1k $19k $13k $1k —
Cash paid for property and equipment ($1.0m) ($392k) ($557k) ($982k) ($599k) ($974k) ($8.1m) —
Proceeds from sale of property and equipment $0 $17k $0 $0 $5k $0 $0 —
Capital Expenditure — — — ($982k) ($599k) ($974k) ($8.1m) ($7.3m)
Net cash used in investing activities ($1.0m) ($375k) ($557k) ($982k) ($594k) ($974k) ($8.3m) ($7.4m)
Issuance Of Debt — — $47.7m $22.0m $0 $0 — $0
Long Term Debt Issuance — — $47.7m $22.0m $0 $0 — $0
Long Term Debt Payments — — — ($22.0m) ($23k) ($13k) ($10k) ($11k)
Net Issuance Payments Of Debt — — — ($28k) ($23k) ($13k) ($10k) ($8k)
Net Long Term Debt Issuance — — — ($28k) ($23k) ($13k) ($10k) ($8k)
Net Short Term Debt Issuance — — ($25.0m) $0 $0 — — —
Repayment Of Debt — — — ($22.0m) ($23k) ($13k) ($10k) ($11k)
Short Term Debt Issuance — — $0 $22.0m $0 — — —
Short Term Debt Payments — — ($25.0m) ($22.0m) $0 — — —
Common Stock Issuance — — $30.4m $0 $0 — — $0
Common Stock Payments — — — $0 ($773k) ($12.0m) ($11.3m) ($21.2m)
Issuance Of Capital Stock — — $30.4m $0 $0 — — $0
Net Common Stock Issuance — — — $0 ($773k) ($12.0m) ($11.3m) ($21.2m)
Repurchase Of Capital Stock — — — $0 ($773k) ($12.0m) ($11.3m) ($21.2m)
Net cash provided by (used in) financing activities ($10.4m)
$2.0m +119.78%
($26.8m) -1407.46%
$3.0m +111.32%
$6.3m +107.32%
($8.3m) -231.89%
($7.5m) +9.19%
($12.4m) -63.95%
Cash, cash equivalents and restricted cash at beginning of the period $36.7m $72.2m $28.7m $19.6m $132.9m $165.9m $198.2m —
Beginning Cash Position — — — $28.7m $19.6m $132.9m $165.9m $168.3m
Restricted cash — — $0 $0 $330k $1.3m $1.3m —
Effects of exchange rate changes on cash and cash equivalents $866k $443k $35k ($178k) $387k ($563k) $834k —
Effect Of Exchange Rate Changes — — — ($178k) $387k ($563k) $834k ($373k)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Provision for credit losses $1.3m $859k $76k $2.6m $260k $1.6m $2.0m —
Unrealized (gain)/loss on derivative instruments $1.2m $4.7m ($2.1m) ($6.6m) $872k $8.2m ($4.7m) —
Noncash lease expense — $0 $0 $1.1m $1.3m $1.0m $1.4m —
Proceeds from exercise of stock awards $6k $885k $177k $3.1m $7.1m $3.7m $3.7m —
Cash paid on notes payable ($3.4m) ($16.9m) $21k ($28k) ($23k) ($13k) ($10k) —
Cash paid to acquire treasury stock ($37k) ($6.9m) ($50.0m) $0 ($773k) ($12.0m) ($11.3m) —
Net increase in cash and cash equivalents $11.3m $35.4m ($43.5m) ($9.1m) $113.2m $33.1m $32.2m —
Cash paid for interest $1.1m $812k $349k $217k $75k $1k $0 —
Cash Flow From Continuing Financing Activities — — — $3.0m $6.3m ($8.3m) ($7.5m) ($12.4m)
Cash Flow From Continuing Investing Activities — — — ($982k) ($594k) ($974k) ($8.3m) ($7.4m)
Change In Account Payable — — — ($16.8m) $24.3m $15.7m $11.2m $23.9m
Change In Cash Supplemental As Reported — — — ($9.1m) $113.2m $33.1m $32.2m —
Change In Payable — — — ($16.8m) $24.3m $15.7m $11.2m $23.9m
Change In Prepaid Assets — — — ($3.6m) ($622k) ($2.7m) $130k ($5.6m)
Changes In Cash — — — ($8.9m) $112.9m $33.6m $31.4m $112.0m
End Cash Position — — — $19.6m $132.9m $165.9m $198.2m $280.3m
Financing Cash Flow — — — $3.0m
$6.3m +107.32%
($8.3m) -231.89%
($7.5m) +9.19%
($12.4m) -63.95%
Free Cash Flow — — — ($11.9m) $106.6m $41.9m $39.0m $124.4m
Gain Loss On Investment Securities — — — ($6.6m) $872k $8.2m ($4.7m) ($3.4m)
Gain Loss On Sale Of PPE — — — $1k $19k $13k $1k $0
Income Tax Paid Supplemental Data — — $2.4m $4.6m $9.9m — — $9.9m
Investing Cash Flow — — — ($982k) ($594k) ($974k) ($8.3m) ($7.4m)
Net Business Purchase And Sale — — — — $0 $0 ($104k) ($104k)
Net PPE Purchase And Sale — — ($557k) ($982k) ($594k) ($974k) — ($7.3m)
Operating Gains Losses — — — ($6.6m) $891k $8.2m ($4.7m) ($3.4m)
Other Non Cash Items — — — $1.1m $1.3m $1.0m $1.4m —
Proceeds From Stock Option Exercised — — — $3.1m $7.1m $3.7m $3.7m $8.9m
Purchase Of Business — — — — $0 $0 ($104k) ($104k)
Purchase Of PPE — — $557k ($982k) ($599k) ($974k) ($8.1m) ($7.3m)
Sale Of PPE — — — $0 $5k $0 $0 $0

Amounts are shown in USD as reported in each fiscal year filing.